home All News open_in_new Full Article

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company’s Refined, Targeted Sales Strategy and Enhanced Patient Support Services ~ ~ PEDMARQSI Now Commercially Available in Germany and the United Kingdom ~ ~ Management to Host Conference Call Today at 8:30 a.m. ET ~ RESEARCH TRIANGLE […]


today 32 h. ago attach_file Economics

attach_file Culture
attach_file Economics
attach_file Technology
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Culture
attach_file Culture
attach_file Other
attach_file Economics
attach_file Sport
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other


ID: 2466467054
Add Watch Country

arrow_drop_down